Become a strategic partner for the industrialisation and commercialisation
of this innovation through an operating licence.
LUCKY
Innovative probiotic to improve the prognosis for animals with cancer
Investment: 430k€
Scope: Health
Scientific field(s): Biology - Medicinal Chemistry
Institution(s): AgroParisTech - INRAE
Development: Technology to be marketed
#1
Unique probiotic strain with proven anti-cancer effects
#2
Non-invasive and accessible solution that preserves the animal’s quality of life
#3
Safe strain (QPS/GRAS) protected by an international patent
USE CASES
An alternative or complementary approach in the form of a dietary supplement for treating cancer in pets, a fatal disease with enormous clinical needs.
APPLICATIONS
A specific strain of Levilactobacillus brevis LBH1073 with unique antiproliferative activities and anticancer properties.
LBH1073 with unique antiproliferative activities and anti-cancer properties.
ADVANTAGES
An easily accessible and non-invasive anti-cancer approach that could also preserve the animal’s quality of life.
Genetically characterised strain.
Strain with QPS/GRAS status.